La Jolla Pharmaceutical Company Stock OTC Bulletin Board
Equities
US5034596040
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2022 | La Jolla Pharmaceutical Announces Management Changes | CI |
2022 | La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index | CI |
Managers | Title | Age | Since |
---|---|---|---|
Michael Hearne
DFI | Director of Finance/CFO | 61 | 20-05-31 |
Tony Hodges
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-11 |
Luke Seikkula
COO | Chief Operating Officer | 60 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marianne Zhen
BRD | Director/Board Member | 55 | 22-08-21 |
Pavel Raifeld
BRD | Director/Board Member | 40 | 22-08-21 |
1st Jan change | Capi. | |
---|---|---|
+2.93% | 108B | |
-3.44% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |